Amlodipine inhibits expression of matrix metalloproteinase-1 and its inhibitor in human vascular endothelial cells

Journal of Cardiovascular Pharmacology

Volumn 35, Issue 6, 2000, Pages 887-890

  Ikeda, Uichi ^a   Hojo, Yukihiro ^a   Ueno, Shuichi ^a   Arakawa, Hiroshi ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Calcium chafinel blocker; Endothelial cell; Matrix metalloproteinase; Plaque rupture

Indexed keywords

AMLODIPINE; COLLAGENASE; COLLAGENASE INHIBITOR; NIFEDIPINE;

ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM;

AMLODIPINE; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HUMANS; MATRIX METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0034128235     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200006000-00009     Document Type: Article

References (5)

1. Rekhter MD, Zhang K, Narayanan AS, Phan S, Schork MA, Gordon D. Type I collagen gene expression in human atherosclerosis. Am J Pathol 1993;143:1634-48.
2. Rekhter MD, Gordon D. Cell proliferation and collagen synthesis are two independent events in human atherosclerotic plaques. J Vasc Res 1994;31:280-6.
3. Pickering JG, Ford CM, Tang B, Chow LH. Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:475-82.
4. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res 1995;77:863-8.
5. Shu YE, Humphries S, Henney A. Matrix metalloproteinases: implication in vascular matrix remodelling during atherogenesis. Clin Sci 1998;94:103-10.